Yes, good point.
Here is some key information from NEU's 27 May 2024 announcement:
So agree with your suggestion. NEU is likely to want to discuss the additional INDs with the FDA first in September to see if they can get their agreement for the safety and tolerability profile to be simplified before announcing any new INDs to the general market.
Yes, good point. Here is some key information from NEU's 27 May...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.63 |
Change
-1.080(6.46%) |
Mkt cap ! $1.997B | |||
| Open | High | Low | Value | Volume |
| $16.61 | $16.65 | $15.54 | $8.354M | 529.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 830 | $15.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.74 | 1484 | 2 |
View Market Depth
| Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |